These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. Li QW, Zheng RL, Ling YH, Wang QX, Xiao WW, Zeng ZF, Fan W, Li LR, Gao YH. Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012 [Abstract] [Full Text] [Related]
7. Prognostic utility of serial 18F-FDG-PET/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment. Fernando S, Lin M, Pham TT, Chong S, Ip E, Wong K, Chua W, Ng W, Lin P, Lim S. Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737 [Abstract] [Full Text] [Related]
8. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer. Karahan Şen NP, Aksu A, Kaya GÇ. Ann Nucl Med; 2020 Dec; 34(12):960-967. PubMed ID: 32951129 [Abstract] [Full Text] [Related]
9. Primary tumor heterogeneity on pretreatment 18F-FDG PET/CT to predict outcome in patients with rectal cancer who underwent surgery after neoadjuvant therapy. Gülbahar Ateş S, Bilir Dilek G, Uçmak G. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023 Dec; 42(4):223-230. PubMed ID: 36690032 [Abstract] [Full Text] [Related]
10. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Lee SJ, Kim JG, Lee SW, Chae YS, Kang BW, Lee YJ, Park JS, Choi GS. Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438 [Abstract] [Full Text] [Related]
11. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Sakin A, Sahin S, Karyagar SS, Karyagar S, Atci M, Akboru MH, Cihan S. J Gastrointest Cancer; 2022 Jun; 53(2):341-347. PubMed ID: 33651265 [Abstract] [Full Text] [Related]
12. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. Niccoli Asabella A, Simone M, Ballini A, Altini C, Ferrari C, Lavelli V, De Luca R, Inchingolo F, Rubini G. Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8227-8236. PubMed ID: 30556862 [Abstract] [Full Text] [Related]
13. Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery. Hotta M, Minamimoto R, Gohda Y, Miwa K, Otani K, Kiyomatsu T, Yano H. Ann Nucl Med; 2021 Jul; 35(7):843-852. PubMed ID: 33948903 [Abstract] [Full Text] [Related]
14. Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy. Nakajo M, Jinguji M, Nakabeppu Y, Nakajo M, Higashi R, Fukukura Y, Sasaki K, Uchikado Y, Natsugoe S, Yoshiura T. Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542 [Abstract] [Full Text] [Related]
15. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC. J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030 [Abstract] [Full Text] [Related]
16. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment 18F-FDG PET/CT Imaging. Beukinga RJ, Hulshoff JB, van Dijk LV, Muijs CT, Burgerhof JGM, Kats-Ugurlu G, Slart RHJA, Slump CH, Mul VEM, Plukker JTM. J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011 [Abstract] [Full Text] [Related]
17. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features. Giannini V, Mazzetti S, Bertotto I, Chiarenza C, Cauda S, Delmastro E, Bracco C, Di Dia A, Leone F, Medico E, Pisacane A, Ribero D, Stasi M, Regge D. Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):878-888. PubMed ID: 30637502 [Abstract] [Full Text] [Related]
18. Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer. Koo PJ, Kim SJ, Chang S, Kwak JJ. Clin Colorectal Cancer; 2016 Dec; 15(4):e213-e219. PubMed ID: 27316919 [Abstract] [Full Text] [Related]
19. Predictive and prognostic potential of volume-based metabolic variables obtained by a baseline 18F-FDG PET/CT in breast cancer with neoadjuvant chemotherapy indication. Garcia-Vicente AM, Pérez-Beteta J, Amo-Salas M, Molina D, Jimenez-Londoño GA, Soriano-Castrejón AM, Pena Pardo FJ, Martínez-González A. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018 Dec; 37(2):73-79. PubMed ID: 29102649 [Abstract] [Full Text] [Related]
20. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Sun W, Xu J, Hu W, Zhang Z, Shen W. Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]